Researching the genetic profile of tumour cells that have spread to cause secondary tumours may provide an avenue to effectively combat metastatic breast cancer.
Sep 29, 2014
0
0
A drug developed by Swiss giant Roche to treat an aggressive form of breast cancer has been shown to extend patients' lives by almost 16 months, researchers said Sunday.
Sep 29, 2014
0
0
Within the first 5 years after the birth of a child, women are at an increased risk of developing metastatic breast cancer. Women diagnosed with postpartum breast cancer have a decreased disease free survival time compared ...
Sep 24, 2014
0
1
Circulating tumor cell (CTC) clusters – clumps of from 2 to 50 tumor cells that break off a primary tumor and are carried through the bloodstream – appear to be much more likely to cause metastasis than are single CTCs, ...
Aug 28, 2014
0
0
Scientists have made it easier to predict both breast cancer relapses and responses to chemotherapy, through the identification of a unique gene. The newly found marker could help doctors classify each breast cancer patient ...
Aug 20, 2014
0
0
Over half of patients being seen in the clinic for a diagnosed brain tumor have metastatic cancer, which has no treatment and detrimental outcomes in most cases.
Jul 24, 2014
0
0
They found the cancer in Colleen Duffey's liver 18 months ago, shortly after the birth of her second daughter. What they discovered next was even more chilling: It wasn't liver cancer at all; it was breast cancer that had ...
Jun 24, 2014
1
0
A recent study evaluating HER2 testing in a large cohort of women with breast cancer found important limitations in the conventional way HER2 testing is performed in the US and internationally.
Jun 18, 2014
0
0
In women with advanced (or metastatic) breast cancer, treatment with the breast cancer drug Trastuzumab (Herceptin) is associated with prolonged survival but also increases the risk of developing heart problems, a new systematic ...
Jun 11, 2014
0
0
Women with metastatic breast cancer to the bone may be able to receive bisphosphonates, the bone-targeting class of drugs like zoledronic acid, less often after the first year of monthly administration. With that practice ...
May 30, 2014
0
0
